The AHA yesterday filed a declaration supporting other organizations seeking a temporary restraining order and preliminary injunction to prevent the Centers for Medicare & Medicaid Services from cutting under its Most Favored Nation Model payments for certain Medicare Part B drugs and biologicals to no more than the lowest price that drug manufacturers receive in other similar countries.

The declaration raised both procedural and substantive concerns, including the lack of proper notice for a rule of this magnitude, the harm the rule’s implementation would likely do to patients, particularly in rural areas, and the inability for providers to negotiate new agreements with drug companies in just three weeks.

Under an interim final rule issued last month, the model will become mandatory Jan. 1 for most hospitals. The Pharmaceutical Research and Manufacturers of America, Association of Community Cancer Centers and others last week filed a federal lawsuit seeking to enjoin enforcement of the rule and declare it unconstitutional and invalid.

Related News Articles

Headline
The Campaign for Sustainable Rx Pricing today launched a grassroots and digital advertising campaign urging policymakers to lower prescription drug prices…
Blog
The availability of swift, accurate and reliable diagnostic testing during the public health emergency has been extremely important. Lab testing is essential…
Headline
The AHA and American Society of Health-System Pharmacists today urged the Food and Drug Administration to take appropriate enforcement action to protect…
Headline
Instead of attacking hospitals and health systems caring for patients during the COVID-19 pandemic, PhRMA should instead focus on lowering the costs of drugs…
Blog
America’s hospitals and health systems, and our heroic caregivers, have been on the front lines of the battle against COVID-19 for the past year, working…
Headline
AHA today urged the Centers for Medicare & Medicaid Services to immediately withdraw its Most Favored Nation model interim final rule and “replace it with…